- Home
- RPAY vs NAGE Comparison
RPAY vs NAGE Comparison
Compare RPAY & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPAY | NAGE |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 314.6M | 261.2M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RPAY | NAGE |
|---|---|---|
| Price | $3.78 | $3.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $5.53 | ★ $16.00 |
| AVG Volume (30 Days) | 431.1K | ★ 738.3K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $309,261,000.00 | $129,423,000.00 |
| Revenue This Year | $12.54 | $16.51 |
| Revenue Next Year | $4.66 | $14.58 |
| P/E Ratio | ★ N/A | $34.00 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $2.30 | $2.87 |
| 52 Week High | $5.90 | $10.52 |
Technical Indicators
Market Signals| Indicator | RPAY | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 44.50 | 41.32 |
| Support Level | $3.39 | $2.87 |
| Resistance Level | $3.87 | $3.61 |
| Average True Range (ATR) | 0.19 | 0.15 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 20.66 | 23.18 |
Price Performance
Historical ComparisonAbout RPAY Repay Holdings Corporation
Repay Holdings Corp is a payments technology company. It provides integrated payment processing solutions to industry-oriented vertical markets in which businesses or other organizations have specific transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments. The company generates majority of its revenue from Consumer Payments segment.
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.